Top Buy
Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.12 | €2.40 | 114.477% |
Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | €17.89 | €26.64 | 48.948% |
Drägerwerk AG & Co. KGaA ST | 3 | 0 | 0 | 0 | €44.40 | €66.00 | 48.649% |
Novo Nordisk A/S | 6 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
Verastem Inc. | 14 | 0 | 0 | 0 | €2.20 | €16.16 | 634.605% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 0 | 0 | €2.35 | €4.62 | 96.492% |
Abbott Laboratories | 20 | 0 | 0 | 0 | €103.88 | €116.25 | 11.906% |
UCB S.A. | 1 | 0 | 0 | 0 | €160.65 | - | - |
Cigna Corp. | 24 | 0 | 0 | 0 | €331.15 | €360.98 | 9.008% |
Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.30 | €35.01 | 33.100% |
Vertex Pharmaceuticals Inc. | 58 | 2 | 0 | 0 | €430.85 | €440.93 | 2.339% |
Bausch Health Companies Inc. | 6 | 0 | 0 | 0 | €5.50 | €12.95 | 135.344% |
Myriad Genetics | 4 | 3 | 0 | 0 | €25.20 | €22.15 | -12.113% |
US Physical Therapy Inc. | 8 | 1 | 0 | 0 | €76.50 | €107.59 | 40.645% |
Dynavax Technologies Corp | 4 | 0 | 0 | 0 | €10.18 | €26.95 | 164.862% |
Edwards Lifesciences Corp. | 32 | 1 | 0 | 0 | €62.27 | €83.40 | 33.940% |
Grifols S.A. | 1 | 0 | 0 | 0 | €9.77 | - | - |
Halozyme Therapeutics Inc. | 22 | 0 | 0 | 0 | €55.46 | €56.47 | 1.819% |
Ipsen S.A. | 1 | 0 | 0 | 0 | €108.40 | €109.00 | 0.554% |
Brookdale Sr Lvg | 5 | 1 | 0 | 0 | €6.40 | €8.27 | 29.206% |
Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.03 | - | - |
Insulet Corp. | 16 | 0 | 0 | 0 | €183.40 | €215.54 | 17.523% |
Masimo Corp. | 7 | 1 | 0 | 0 | €106.20 | €151.02 | 42.208% |
Smith & Nephew plc ADR | 3 | 0 | 0 | 0 | €27.40 | - | - |
Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |